MedTrace Logo

Self-management Compared to Care-as-usual for Men With Lower Urinary Tract Symptoms

NCT05356260 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2024-12-13

No results posted yet for this study

Summary

Research question: Does offering an online self-management program lead to more efficient use of care by men with urinary complaints? Hypothesis: Many men with urinary symptoms receive medication from their GP. Advice on how to self-manage complaints is often skipped. This while self-management is effective. By offering self-management instead of visiting a GP the use of care by men with urinary complaints may decrease and treatment may become more efficient.

Study design: Men are randomized to receive either care-as-usual by their GP or the online self-management program. Men will be followed for six months and the cost-effectiveness of the online self-management intervention will be compared to the care-as-usual

Conditions

  • Lower Urinary Tract Symptoms

Interventions

DEVICE

URincontrol4men

The intervention is built as an app

OTHER

Care as usual

CAU will be that typically provided by GPs. Also patients will be informed about a page on thuisarts.nl regarding male LUTS. The pragmatic trial design means that care can vary depending on the preferences of patients and GPs in this group.

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Bekkenbodem4All

    collaborator UNKNOWN

  • Leiden University Medical Center

    collaborator OTHER

  • University of Twente

    collaborator OTHER

  • Isala

    collaborator OTHER

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Marco Blanker · University Medical Center Groningen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-08
Primary Completion
2024-12-05
Completion
2024-12-05

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05356260 on ClinicalTrials.gov